parkinson glutathione oxidative

parkinson glutathione oxidative Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Precursors and Beyond Parkinson's Disease Treatment | IV

Name: parkinson glutathione oxidative Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Precursors and Beyond Parkinson's Disease Treatment | IV
Brand: equiscorp.hu
SKU: 72728002015
Price: 23.37 USD
Availability: InStock
Rating: 4.1215 (28 reviews)

Parkinson's Disease Treatment IV Glutathione for Parkinson's Ferroptosis in Parkinson's disease: glianeuron crosstalk: Trends in Molecular Medicine Glutathione, iron and Parkinson's disease ScienceDirect Oxidative stress and cellular pathologies in Parkinson's disease Molecular Brain Springer Nature Link

SKU: 72728002015 · From equiscorp.hu

4.1

USD23.37 USD72.37

Pay in 4 interest-free payments of $5.84 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

doi: 10.1371/journal.pone.0255716

Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide naturally present in human blood plasma at concentrations averaging 200 ng/mL at age 20, declining to approximately 80 ng/mL by age 60

Additionally, OGD treatment resulted in a significant increase in FOXO4 expression (Figure 3C), and the accumulation of FOXO4 in the nucleus was more evident through immunofluorescence technology